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Abstract 
Next‑generation sequencing (NGS) technologies are increasingly being used to address a diverse range of biological 
and epidemiological questions. The current understanding of malaria transmission dynamics and parasite movement 
mainly relies on the analyses of epidemiologic data, e.g. case counts and self‑reported travel history data. How‑
ever, travel history data are often not routinely collected or are incomplete, lacking the necessary level of accuracy. 
Although genetic data from routinely collected field samples provides an unprecedented opportunity to track the 
spread of malaria parasites, it remains an underutilized resource for surveillance due to lack of local awareness and 
capacity, limited access to sensitive laboratory methods and associated computational tools and difficulty in inter‑
preting genetic epidemiology data. In this review, the potential roles of NGS in better understanding of transmission 
patterns, accurately tracking parasite movement and addressing the emerging challenges of imported malaria in low 
transmission settings of sub‑Saharan Africa are discussed. Furthermore, this review highlights the insights gained from 
malaria genomic research and challenges associated with integrating malaria genomics into existing surveillance 
tools to inform control and elimination strategies.
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Background
In 2017, there were approximately 198 million cases of 
malaria and 400,000 malaria-related deaths in sub-Saha-
ran Africa (SSA) [1]. This burden is highly heterogene-
ous; 10 countries contributed 70% of the total reported 
cases [1], while others made substantial progress towards 
realizing elimination as an attainable goal [2]. This het-
erogeneous nature of malaria distribution in SSA has 
resulted in countries with very low transmission sharing 
borders with higher transmission countries, a scenario 
clearly evidenced in southern Africa [3]. On a finer scale, 
this phenomenon extends to neighboring regions within 
the same country, and has resulted in some SSA countries 
implementing subnational targeted malaria elimination 
strategies [4, 5].
Spread of malaria from higher to lower transmission 
areas is not a new challenge, but has become a more 
pressing issue given the recent progress in malaria con-
trol and increasing connectivity between SSA countries 
driven by increased population movements [6]. In areas 
of low malaria transmission, an apparent “outbreak” 
of cases could merely arise from imported cases and 
could present a barrier to achieving malaria elimination 
[7] (Fig.  1). Imported malaria remains difficult to iden-
tify and address using the surveillance tools and limited 
resources currently available to most National Malaria 
Control Programmes (NMCPs). While existing surveil-
lance measures (e.g. parasite rate, case incidence and 
reported travel histories) are fundamental to answering 
some of these questions, they are often limited by con-
sistency and accuracy, particularly in areas with highly 
mobile and migrant populations.
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Recent advances in malaria genomics, when com-
bined with epidemiologic data, offer the potential 
to improve our ability to track the spread of malaria 
[8–12]. Several studies have highlighted the value of 
malaria genomics in epidemiological and public health 
settings (reviewed by [11–13]). Most of these stud-
ies have relied on traditional genotyping methods to 
understand transmission dynamics [14, 15]; to deter-
mine connectivity between populations [16–18]; to 
classify local and imported infections [19] and to track 
the spread of drug resistance as discussed by Ishengoma 
et al. in this technical series [20]. The increasing acces-
sibility of high throughput next-generation sequencing 
(NGS) now provides an opportunity to refine exist-
ing tools and develop high resolution approaches [17, 
21–27]. Despite this potential, molecular epidemiology 
approaches are not yet fully operationalized to inform 
intervention strategies in SSA. In this review, how 
malaria genomics can improve the understanding of 
malaria transmission dynamics by enabling the track-
ing of parasite flow between populations and its prom-
ise to address the challenges of identifying imported 
infections are discussed. This review highlights the 
major challenges in study design, gaps in laboratory 
and analytical methods and translating genomic data 
into calibrated epidemiologic parameters. Furthermore, 
issues surrounding logistics, local capacity, communi-
cation between researchers and NMCPs and the need 
to establish a framework for actionable genomic epide-
miology studies in SSA are highlighted.
Genomic epidemiology of malaria: 
from transmission to translation
Estimating population level transmission from genomic 
data
Parasite genetic data from polymorphic loci (e.g. micros-
atellites and highly diverse genes); single nucleotide poly-
morphisms (SNP) and whole genome sequences (WGS) 
have been used to characterize transmission dynamics 
[11, 13, 14]. It is generally believed that as malaria trans-
mission declines, complexity of infection and genetic 
diversity decreases, leading to spatial fragmentation of 
parasite populations [11, 28–31]. This association can 
ideally be leveraged to assess the level of ongoing local 
transmission and evaluate the impact of control or elimi-
nation interventions [32]. In this context, genomic data 
would augment traditional surveillance methods, and 
may be particularly useful in settings where surveillance 
infrastructure is limited or where traditional metrics are 
insensitive to relevant changes in transmission. Within-
host and population level genetic indices have both been 
used to measure transmission intensity.
Measuring within‑host genetic indices
Within-host parasite diversity can arise from sequential 
bites from mosquitoes that are infected with genetically 
distinct strains (superinfection) or more commonly 
from a single mosquito bite containing multiple strains, 
some of which may be closely related (co-transmission) 
[33]. Traditionally, within-host parasite diversity is 
measured by characterizing a few polymorphic loci to 
Fig. 1 Variation in malaria transmission intensity in 45 sub‑Saharan Africa countries (data from) (a). Distribution of malaria incidence in 2017. 
b Temporal change in the incidence of malaria in low (incidence 0–50 per 1000 population at risk), medium (incidence 50–100) and high 
(incidence > 100) transmission countries of SSA. Data source: http://apps.who.int/gho/data/node.imr.SDGMA LARIA ?lang=en
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determine the minimum number of genetically distinct 
parasite strains present (i.e. multiplicity of infections, 
MOI) (reviewed by Zhong et al. [33]), but these meth-
ods have limited inter-laboratory reproducibility and 
comparability among studies. SNP panels and analytical 
tools have been developed to mitigate the limitations of 
size-polymorphic markers [15, 34–37]. However, SNPs 
begin to lose resolution in highly complex infections 
where most loci with reasonable diversity will result in 
heterozygous calls. Advances in NGS technologies have 
made it possible to develop highly sensitive targeted 
deep sequencing approaches [22, 38–43]. These data 
can provide information not only the number of strains, 
but also the genetic diversity [e.g. the within-host 
diversity index (Fws)] as well as relatedness and genetic 
structure of parasites in an infection [22, 43–46]. 
Multi-locus deep sequencing data can provide informa-
tion on the number and genetic relatedness of strains 
in an infection, which can be utilized to evaluate spa-
tial differences and temporal changes in transmission. 
A recent exciting development is the ability to sequence 
single infected red blood cells, providing high-resolu-
tion data, including the ability to understand drivers of 
genetic diversity within naturally occurring infections 
and to unambiguously phase genetic data from mixed 
infections [33, 47]. However, these methods are not yet 
easily scalable to the levels required for most epidemio-
logic work, requiring additional development.
In malaria-endemic regions, multiple infections are 
common, and within-host diversity indices broadly cor-
relate with endemicity in a non-linear fashion [14, 28–
32, 44, 48–50]. Reduced within-host diversity has been 
associated with increased ITN use [51] and temporal 
changes in transmission [50, 52, 53], indicating that 
theses metrics may be reasonable indicators of changes 
in transmission intensity. However, these relationships 
may be more difficult to interpret in areas where infec-
tions are not at a steady-state, and in particular may 
not reflect local transmission intensity, even amongst 
locally acquired infections, in areas with high rates 
of importation [54]. Although NGS technologies are 
advancing quantification of within-host diversity, they 
have also introduced new challenges. For example, the 
depth of sequencing can dramatically affect within-host 
diversity indices and comparability of findings between 
studies. Therefore, study design and the sequenc-
ing workflow including sample preparation, choice of 
sequencing platform, sequencing depth and sequence 
processing pipelines would benefit from standardiza-
tion across molecular epidemiology studies. Similarly, 
the sensitivity of computational methods to identify 
genetic variants and associated errors are crucial for 
the successful establishment of NGS-based inference of 
transmission and the possibility to integrate these tools 
for routine surveillance.
Measuring population level genetic indices
While population level genetic diversity is complex, there 
are a range of genetic measures, including heterozygo-
sity (or homozygosity), effective population size, linkage 
disequilibrium, proportions of genetically related infec-
tions and others [11, 12]. These indices have been tradi-
tionally generated using microsatellites and SNP panels. 
However, NGS offer the potential to provide data at a 
greater breadth to evaluate the genetic relatedness of 
parasites within and between infections. Several methods 
(such as DEploidIBD [44], DEploid [55], hmmIBD [56] 
and isoRelate [57]) are now available to identify genomic 
regions that are shared between isolates thereby detect-
ing whether pairs of infections within and between popu-
lations are genetically related or not.
Several studies have compared the spatial differences 
in these indices and evaluated changes over time. Declin-
ing transmission has been associated with increase in 
linkage disequilibrium, reduction in parasite genetic 
diversity and effective population size likely as a result 
of population bottlenecks and fragmentation of parasite 
populations [11, 12]. However, the relationships between 
transmission intensity and changes in genomic indices 
are unlikely to be linear and uniform across settings. A 
recent study in the Kingdom of Eswatini [54], a country 
with a yearly malaria incidence of < 1 malaria case per 
1000 population at risk, revealed a high level of parasite 
diversity. The authors found that this seemingly paradox-
ical finding was consistent with transmission driven by a 
high proportion of imported infections with a few, short 
chains of local transmission, a finding supported by the 
NMCP’s classification of most cases as imported based 
on travel history data. Findings such as this highlight the 
challenge of applying broad genetic relationships to sce-
narios where transmission is dynamic—with dramatic 
changes in transmission occurring over short spatial and/
or temporal scales. Such areas may represent the rule 
rather than the exception in low and very low transmis-
sion settings of SSA where effective interventions may 
increase heterogeneity in transmission [16] Therefore, 
additional work is needed to determine sampling frames, 
relevant meta-data and appropriate statistical frame-
works to obtain calibrated transmission metrics from 
genomic data such that these data can complement exist-
ing tools and improve the scale and resolution of popula-
tion level inference of transmission.
Inferring connectivity from parasite genetic data
Genetic data are often used to estimate connectivity 
between populations and track the spread of infectious 
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diseases. In malaria, the genetic relatedness of infections 
can be compared at different scales to determine spatial 
patterns of transmission [8, 16, 22, 58, 59]. Infections 
with the same or highly similar genomes linked by epi-
demiologic data, are likely to represent infections that are 
related by transmission. The genetic resolution required 
to distinguish the relatedness of infections over a given 
number of transmission events depends on the underly-
ing transmission intensity; the spatial scale of the study; 
sampling frameworks and parasite density (e.g. sympto-
matic and/or asymptomatic samples) and the ability of 
the assay to detect genetically distinct strains in poly-
clonal and low-density infections.
Over the years, several analytical methods to infer pop-
ulation structure have been developed [60–62]. However, 
genetic relatedness-based approaches have recently been 
shown to provide a greater resolution to identify geo-
graphic regions that are linked by transmission [16, 58, 
59]. These approaches have the potential to define spatial 
patterns in low to moderate transmission areas. How-
ever, genetic relatedness metrics alone are not enough 
to accurately estimate importation; analytical tools to 
translate genetic connectivity to demographic connectiv-
ity (e.g. the number of parasites imported from one loca-
tion to the other) are required. This is a major problem in 
most areas of SSA where human connectivity and para-
site flow occurs between genetically intermixed popula-
tions. However, the availability of reference WGS data 
and resultant ability to inform geographically informative 
target selection frameworks targets, would improve the 
resolution of genetic data to accurately assign parasites to 
their geographic origin.
Beyond population level estimates of connectivity, 
parasite genomics offers enormous potential to deter-
mine person-to-person transmission chains [63]. These 
approaches are routine for viral and bacterial diseases 
[64, 65] but are not yet readily applicable for sexually 
recombining pathogens such as malaria. Tracking of 
infections using this approach is based on the genetic 
similarity between the ensemble of parasites present in 
each of a pair of infections representing a potential trans-
mission event. Therefore, the accuracy of transmission 
chains is dependent on the genetic resolution (i.e. the 
informativeness of genetic targets and the sensitivity of 
genotyping methods); the proportion of infections sam-
pled; the available epidemiologic meta-data; the analyti-
cal methods and the context within which these methods 
are applied. In SSA, where imported infections are often 
highly complex and diverse [16, 66], genotyping methods 
must be able to detect minority strains from low density 
infections by targeting regions of the genome that exhibit 
genetic diversity sufficient to provide individual strain 
identification in mixed infections.
Classification of local and imported infections using 
parasite genetic data
Malaria importation poses a complex challenge in low 
transmission countries of SSA [7]. Despite the success 
of malaria control over the past decade, recent reports 
show an increase in the number of clinical cases in pre-
elimination countries, which is mainly attributed to 
importation from neighboring higher transmission areas 
[1, 3] (Fig.  1b). These challenges are more pronounced 
in southern Africa, where malaria eliminating countries 
are being challenged by cross-border importation from 
higher transmission countries [3, 67, 68]. For example, 
more than 50% of malaria cases in Eswatini and South 
Africa were classified as imported based on reported 
travel history of patients [3, 67, 68]. Progress towards 
elimination requires novel approaches with improved 
accuracy to classify imported malaria and measure its 
impact on local transmission. Molecular epidemiology 
provides an as yet untapped opportunity to address these 
challenges.
NGS can provide high-throughput genomic data 
from routinely collected field samples (e.g. dried blood 
spots and used RDTs), however even the best genetic 
data alone cannot be expected to accurately reconstruct 
transmission chains. Availability of a toolbox of appro-
priate analytical methods that combine parasite genom-
ics and epidemiological data [8], would be very useful for 
reconstruction of transmission chains and derivation of 
other transmission metrics. Furthermore, this approach 
can provide information on the number of secondary 
cases arising from each imported infection, allowing 
programmes to directly measure receptivity and deter-
mine what if any interventions are required to prevent 
re-establishment of transmission in an eliminating area. 
Therefore, a multidisciplinary team of modellers, molec-
ular epidemiologists, programme officers and other 
stakeholders need to work together to fully harness the 
potential of malaria genomics to address the current and 
future challenges of imported malaria in very low trans-
mission settings of SSA.
Challenges and priorities for the translation 
of malaria genomic epidemiology
Genomic epidemiology has grown rapidly over the past 
decade, facilitated by decreasing costs, increased effi-
ciency of NGS technologies as well as improved infra-
structure for data management and analysis. These 
improved technologies have enabled researchers to 
explore how malaria genomics can help improve the 
understanding of transmission dynamics and flow of par-
asites. However, translation of findings to inform control 
and elimination and its applications in SSA has lagged 
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behind other regions owing to a number of factors, some 
of which are illustrated in Fig. 2 and discussed below.
Challenges of integrating with routine surveillance 
systems
Integration of genomic data into malaria surveillance is 
a relatively recent phenomenon, largely facilitated by 
the rapid increase in accessibility to these technologies. 
While this makes the field very exciting scientifically, 
there is limited evidence on the utility of these methods 
to provide timely and actionable data. There are even 
fewer data available to guide standardization or best 
practices on the types of sampling frames to consider, 
genomic data to generate, and analytical plans to employ 
in order to answer epidemiologically relevant ques-
tions. Although these types of evidence are rapidly being 
generated, it is understandably difficult for research 
groups and other stakeholders interested in evaluating 
or deploying these technologies to obtain buy in from 
the relevant field partners. Some NMCPs may not con-
sider genomic epidemiology as an integral part of their 
suite of surveillance tools or even one worth investigat-
ing through operational research. For under-resourced 
NMCPs where achieving adequate coverage of basic con-
trol interventions is a major challenge, genomics may be 
viewed as a costly luxury that they can ill afford. What 
is often not appreciated by programmes and donors, and 
in truth is currently difficult to formally evaluate, is the 
cost of deploying (or not deploying) expensive interven-
tions based on substandard surveillance data. Therefore, 
there is very urgent need for discussions and operation-
ally relevant studies that highlight the value of genomic 
epidemiology. In addition, it is essential that standardized 
frameworks are created which enable the integration of 
genomic epidemiology into existing surveillance sys-
tems in low and very low transmission areas of SSA. The 
potential applications of genomic epidemiology depend 
on the timely, efficient collection of samples, as well as 
access to sample information and associated meta-data, 
which should be leveraged through existing surveillance 
programs such as health facility-based surveillance, 
malaria indicator surveys (MIS), therapeutic efficacy 
Fig. 2 Challenges and key priorities of genomic epidemiology in sub‑Saharan Africa
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studies (TES) and others. These approaches provide cost-
effective and scalable platforms, which help establish 
efficient and equitable collaboration with NMCPs while 
addressing programmatic questions without requiring 
much if any costs for additional sampling.
Challenges with laboratory methods and data analyses
Two major challenges associated with laboratory-based 
analyses in SSA are the sensitivity of the technology 
required to generate high quality data from low-density 
infections and the detection of relevant strains in highly 
polyclonal infections. The ability to obtain epidemio-
logically useful information from the genomes of mixed 
infections is an issue in most of SSA, where polyclonal 
infections are often the rule rather than the exception 
even in relatively low transmission areas [16, 66, 69]. 
Advances in NGS have enabled the whole genome and 
targeted sequencing of malaria from routinely collected 
field samples [70], but no single method is universally 
applicable for all contexts. WGS can provide the near 
complete genome of the parasite, while targeted NGS 
can generate data at specific loci of interest. Although 
both approaches rely on a more or less similar laboratory 
workflow, the required quantity and quality of DNA; cost, 
laboratory processing, data storage, and computational 
time differ significantly. Unlike WGS, targeted sequenc-
ing provides greater depth of sequencing allowing for 
improved detection of minority strains in an infection 
and more robust comparisons between samples, since 
amplification of targeted loci is deeper and more con-
sistent. However, identification of informative genomic 
regions and the capability to effectively multiplex these 
targets are challenges that need to be overcome to fully 
realize the utility of this method. Which and how many 
targets provide sufficient information to track the flow of 
parasites or determine their origin from different regions 
of SSA is currently unknown. Furthermore, it is appeal-
ing to develop combined panels to efficiently answer 
multiple questions, such as transmission epidemiology 
and prevalence of molecular markers of drug resistance. 
Therefore, optimization of sensitive laboratory methods 
and the development of well calibrated and accessible 
data analyses tools need to be prioritized and addressed.
Challenges with local infrastructure and capacity
Despite the potential of NGS technologies, there are 
many challenging and costly bridges to cross in order to 
realize its full potential and application in SSA. The lack 
of local capacity in many SSA countries is the result of 
many complex issues, including limited infrastructure, 
the shortage of African expertise in malaria genomics 
and the lack of adequate support by African governments 
and international donors. There are efforts to overcome 
some of these limitations (e.g. The Malaria Genomic 
Epidemiology Network (MalariaGEN), The Plasmodium 
Diversity Network Africa (PDNA), MRCG-LSHTM 
genomics and high-performance computer centers and 
others), however a sustainable approach will, in part, 
depend on African scientists advocating for govern-
ments and international funders to build local facilities 
and establish sustainable collaborative platforms to train 
and attract skilled staff necessary to lead malaria genom-
ics in SSA. One model would be to advocate for funding 
of regional genomics centers, which can provide services 
to geopolitical blocs. These would help to galvanize adop-
tion and ensure sustainability, since local scientists and 
control program staff would be directly invested in the 
process and as such be able to better direct the outcome.
Challenges with communication of findings
Genomic surveillance, coupled with high quality meta-
data, can provide valuable input for the development of 
policies for malaria elimination and eventual eradica-
tion. Critical to the success of any control/elimination 
programme is the involvement of and ownership by 
the respective local governments. For example, WHO-
recommended TES have allowed strong partnership 
between NMCPs and researchers to plan, implement and 
report findings [71]. These partnerships also extend to 
the dissemination of findings to policy makers and devel-
opment of policy recommendations, particularly when 
changes of first-line anti-malarials are required. Experi-
ence gained from such initiatives need to be formalized 
and utilized to develop efficient and sustainable part-
nerships between researchers and NMCPs for a broader 
range of molecular epidemiology studies. In the context 
of wide adoption and utilization of genomic data to sup-
port malaria elimination strategies, NMCPs should be 
capacitated on the added value and how genomic data 
can be integrated to inform routine activities of the pro-
grammes. The programmes also need to be supported 
and sensitized to appreciate how genetic data can poten-
tially support and influence the process of changing dif-
ferent malaria control/elimination policies. Whenever 
possible, the NMCPs should play a central role in the 
planning and implementation of genomic studies in 
order to ensure that the research address questions of rel-
evance and priority in the local context. Ensuring adop-
tion of malaria control or elimination policies guided 
by research findings must be a joint effort of NMCP, 
researchers and other key stakeholders. Finally, the para-
site genetic surveillance findings must be disseminated to 
key stakeholders and policy makers in language that they 
clearly understand. Making the data interpretable and 
accessible, e.g. by using maps and interactive visualiza-
tion tools, must be a priority for genomics surveillance.
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Data sharing and accessibility
The cost of sequencing has dropped significantly, result-
ing in the rapid generation of genomic data by research-
ers from developing and developed countries. An 
important benefit of NGS data is that it can be shared 
and may be directly compared, even if the sequences 
were generated by different laboratories. Data sharing is 
essential for enabling and promoting malaria genomic 
research in a way that will maximize the outcomes from 
molecular epidemiology studies and provide resources 
for the development and validation of laboratory and 
analytical tools. There are encouraging efforts in data 
sharing by the malaria community (e.g. the pioneering 
efforts demonstrated by MalariaGEN and PlasmoDB). 
However, consistent deposition of sequence data from 
various scientists into standardized repositories is not 
yet coordinated at the scale seen in other fields. It is chal-
lenging to formulate efficient solutions for data standard-
ization, formatting, archiving and access in the absence 
of a dedicated repository for malaria genomic data. In 
the context of SSA, limited access to high-speed internet 
and computational capacity presents a barrier for Afri-
can researchers to access and utilize publicly available 
genomic data. In the future, platforms such as PlasmoDB 
or any newly designed dedicated data sharing platform 
must adequately address the challenges and bottlenecks 
in malaria genomic data sharing (e.g. ethical, adminis-
trative, logistic and data management issues) and their 
accessibility by SSA researchers.
Conclusions and future perspectives
NGS technologies hold enormous potential for scien-
tists and malaria control program personnel in SSA to 
improve their understanding of malaria transmission 
dynamics, including the ability to tracking the spread 
of parasites between populations or from one individ-
ual to the other. Ultimately, with sufficient reference 
genomes from multiple sites, it may be possible to accu-
rately assign infections to their geographic origin. This 
information would help to address the formidable chal-
lenges of accurately evaluating imported malaria in low 
and very low transmission settings. It is clear that sensi-
tive laboratory methods, appropriate analytical and dis-
semination tools, and accessible data sharing platforms 
need to be prioritized and developed to materialize 
the promises of malaria genomics, especially in SSA. 
Strategies for sample collection that leverage existing 
surveillance systems and, when appropriate, standardi-
zation of study designs will help to facilitate sustainable 
partnerships between researchers, NMCPs, and other 
stakeholders. African researchers need to play a leading 
role in advocating for international donors and African 
governments to build local capacity, possibly through 
regional genomic epidemiology hubs that can spear-
head the generation of data to inform malaria elimina-
tion and eradication policies on the continent.
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